BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16966733)

  • 21. Prices and availability of pharmaceuticals: evidence from nine countries.
    Danzon PM; Furukawa MF
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-521-36. PubMed ID: 15506157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cost reductions and their effects on drug research].
    Götte D
    Med Klin (Munich); 2005 Jun; 100(6):309-13. PubMed ID: 15968482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International trade and determinants of price differentials of insulin medicine.
    Helble M; Aizawa T
    Health Policy Plan; 2017 Feb; 32(1):1-10. PubMed ID: 27346189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
    Vogler S; Vitry A; Babar ZU
    Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. It's the prices, stupid: why the United States is so different from other countries.
    Anderson GF; Reinhardt UE; Hussey PS; Petrosyan V
    Health Aff (Millwood); 2003; 22(3):89-105. PubMed ID: 12757275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health care reform in the United States: radical surgery needed now more than ever.
    Manchikanti L
    Pain Physician; 2008 Jan; 11(1):13-42. PubMed ID: 18196168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care spending growth: how different is the United States from the rest of the OECD?
    White C
    Health Aff (Millwood); 2007; 26(1):154-61. PubMed ID: 17211024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.
    Morgan SG; Leopold C; Wagner AK
    CMAJ; 2017 Jun; 189(23):E794-E799. PubMed ID: 28606975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Datawatch: Update on Rx drug spending.
    Bus Health; 2001 Sep; 19(8):48. PubMed ID: 11665673
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of permanent and transitory shocks in explaining international health expenditures.
    Narayan PK; Narayan S
    Health Econ; 2008 Oct; 17(10):1171-86. PubMed ID: 18076005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Data watch. The scoop on Rx drug spending.
    Bus Health; 2001 Jun; 19(6):48. PubMed ID: 11434100
    [No Abstract]   [Full Text] [Related]  

  • 32. U.S. health care spending in an international context.
    Reinhardt UE; Hussey PS; Anderson GF
    Health Aff (Millwood); 2004; 23(3):10-25. PubMed ID: 15160799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The global market for ADHD medications.
    Scheffler RM; Hinshaw SP; Modrek S; Levine P
    Health Aff (Millwood); 2007; 26(2):450-7. PubMed ID: 17339673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Price differences between Japan and the US for medical materials and how to reduce them.
    Ide H; Yasunaga H; Imamura T; Ohe K
    Health Policy; 2007 Jun; 82(1):71-7. PubMed ID: 17028042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prices for innovative pharmaceutical products that provide health gain: a comparison between Australia and the United States.
    Roughead EE; Lopert R; Sansom LN
    Value Health; 2007; 10(6):514-20. PubMed ID: 17970935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The determinants of pricing in pharmaceuticals: are US prices really so high?
    Cabrales A; Jiménez-Martín S
    Health Econ; 2013 Nov; 22(11):1377-97. PubMed ID: 23303712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of price regulation on the launch delay of new drugs--evidence from twenty-five major markets in the 1990s.
    Danzon PM; Wang YR; Wang L
    Health Econ; 2005 Mar; 14(3):269-92. PubMed ID: 15386651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stats & facts. Global health cost and care comparisons.
    Manag Care Interface; 2002 Jul; 15(7):66-7. PubMed ID: 12143300
    [No Abstract]   [Full Text] [Related]  

  • 39. Insurers' strategies for managing the use and cost of biopharmaceuticals.
    Robinson JC
    Health Aff (Millwood); 2006; 25(5):1205-17. PubMed ID: 16966716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The growth of prescription drug costs and national health expenditures.
    Cole DL
    Med Interface; 1995 Mar; 8(3):42-3. PubMed ID: 10141387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.